Evaluating the safety profile of anti-platelet therapy in patients undergoing elective inguinal hernia repair: a systematic review and meta-analysis

医学 荟萃分析 置信区间 优势比 腹股沟疝 随机对照试验 外科 输血 内科学
作者
Matthew G. Davey,William Joyce
出处
期刊:Irish Journal of Medical Science [Springer Science+Business Media]
卷期号:193 (2): 897-902
标识
DOI:10.1007/s11845-023-03480-w
摘要

Abstract Introduction There remains no consensus surrounding the safety of prescribing anti-platelet therapies (APT) prior to elective inguinal hernia repair (IHR). Aims To perform a systematic review and meta-analysis evaluating the safety profile of APT use in patients indicated to undergo elective IHR. Methods A systematic review was performed in accordance with PRISMA guidelines. Meta-analyses were performed using the Mantel–Haenszel method using the Review Manager version 5.4 software. Results Five studies including outcomes in 344 patients were included. Of these, 65.4% had APT discontinued (225/344), and 34.6% had APT continued (119/344). The majority of included patients were male (94.1%, 288/344). When continuing or discontinuing APT, there was no significant difference in overall haemorrhage rates (odds ratio (OR): 1.86, 95% confidence interval (CI): 0.29–11.78, P = 0.130) and in sensitivity analysis using only RCT data (OR: 0.63, 95% CI: 0.03–12.41, P = 0.760). Furthermore, there was no significant difference in reoperation rates (OR: 6.27, 95% CI: 0.72–54.60, P = 0.590); however, a significant difference was observed for readmission rates (OR: 5.67, 95% CI: 1.33–24.12, P = 0.020) when APT was continued or stopped pre-operatively. There was no significant difference in the estimated blood loss, intra-operative time, transfusion of blood products, rates of complications, cerebrovascular accidents, myocardial infarctions, or mortality observed. Conclusion This study illustrates the safety of continuing APT pre-operatively in patients undergoing elective IHR, with similar rates of haemorrhage, reoperation, and readmission observed. Clinical trials with larger patient recruitment will be required to fully establish the safety profile of prescribing APT in the pre-operative setting prior to elective IHR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
华仔应助机灵飞阳采纳,获得10
2秒前
潘善若发布了新的文献求助10
2秒前
3秒前
陈少华完成签到 ,获得积分10
3秒前
下一秒发布了新的文献求助10
4秒前
杨乃彬完成签到,获得积分10
4秒前
取名叫做利完成签到,获得积分10
5秒前
赘婿应助喻义梅采纳,获得10
6秒前
小二郎应助小门采纳,获得10
7秒前
ll发布了新的文献求助10
10秒前
正直的鸿完成签到,获得积分10
15秒前
16秒前
万能图书馆应助高贵梦露采纳,获得10
17秒前
momo发布了新的文献求助10
19秒前
传奇3应助boltos采纳,获得10
20秒前
20秒前
21秒前
要减肥笑阳完成签到 ,获得积分10
22秒前
全若之发布了新的文献求助10
27秒前
Jasper应助momo采纳,获得10
29秒前
Kasom完成签到 ,获得积分10
36秒前
顺利一德完成签到,获得积分20
37秒前
香蕉觅云应助Afaq采纳,获得10
37秒前
37秒前
37秒前
manman完成签到,获得积分10
38秒前
38秒前
哈哈哈完成签到,获得积分10
38秒前
YamDaamCaa应助科研通管家采纳,获得30
39秒前
39秒前
领导范儿应助科研通管家采纳,获得10
39秒前
香蕉觅云应助科研通管家采纳,获得10
39秒前
39秒前
大个应助科研通管家采纳,获得10
39秒前
czh应助科研通管家采纳,获得20
39秒前
科研通AI2S应助科研通管家采纳,获得10
39秒前
酷波er应助科研通管家采纳,获得10
39秒前
纯情的天奇完成签到 ,获得积分10
41秒前
顺利一德发布了新的文献求助10
42秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989263
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253814
捐赠科研通 3270066
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136